Health Ministry to conduct 1 lakh tests per day with Indian kits by May

NEW DELHI: India will produce its rapid antibody testing kits independently and RTPCR diagnostic kits by May and the country would try to make possible to meet the target of one lakh tests per day by the end of May, health minister Harsh Vardhan said.
Vardhan said, “Out of at least half a dozen candidates supported for vaccines, four are in an advanced stage. Regulatory platform in one place has been constituted for speedy clearances.”

Vardhan addressed scientists of autonomous institutes and PSUs under the department of biotechnology before reviewing their work relating to Covid-19 solutions.
Scientists said, “at least nine of these studies were in early stages and one delivery and adjuvant system for improving immunogenicity of the candidate vaccine was at an advanced stage.”

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid